Percentage of Assured Money Vs. Total Potential Value in Pre-Commercial Stage Licensings, '92-'94
Executive SummaryIn our statistical review, we chart the variation, year by year, in the average amount of money guaranteed to the licenser of a pre-commercial stage product as a percentage of the total potential value of the deal. It's been falling.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.